K
Kura Oncology, Inc. (KURA)
NMS – Real Time Price. Currency in USD
10.90
+0.54 (5.21%)
At close: Jun 26, 2026, 4:00 PM EDT
10.97
+0.07 (0.64%)
After-hours: Jun 26, 2026, 7:31 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
10.90
+0.54 (5.21%)
At close: Jun 26, 2026, 4:00 PM EDT
10.97
+0.07 (0.64%)
After-hours: Jun 26, 2026, 7:31 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.15 | 6.05 | 10 | |
| Quick ratio | 6.14 | 5.63 | 10 | |
| Debt to Equity | 0.23 | 0.30 | 8.0 | |
| Debt to Assets | 0.04 | 1.04 | 9.0 | |
| Interest coverage | -234.57 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 54M | 67M | 72M |
| Gross Profit | -759K | -849K | 53M | 66M | 70M |
| Operating Income | -140M | -166M | -193M | -304M | -318M |
| Net Income | -136M | -153M | -174M | -279M | -295M |
| EBITDA | -139M | -165M | -192M | -303M | -317M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 31.88 | -19.34 | 5.5 |
| Next quarter | 12.7 | -7.18 | 4.5 |
| Current year | 40.84 | -11.47 | 5.5 |
| Next year | 125.8 | 25.13 | 10 |
| Weighted average score | 6.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 5.36 | 9.46 | 9.78 | -174.79 | 4.5 |
| Y/Y | 29.47 | -27.68 | -25.75 | -19.05 | 3.3 |
| 3y average | 674.41 | -28.82 | -18.99 | 13.79 | 5.0 |
| 5y average | 804.25 | -27.22 | -15.31 | -2.02 | 3.3 |
| Weighted average score | 4.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $39.1M significantly exceed its total debt $24.3M, ensuring strong financial flexibility
Total current assets $623.8M exceed Total current liabilities $101.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-234.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$86.0M limits the company's ability to reinvest or pay down debt